<p>Tempus AI（纳斯达克代码：TEM）上涨约 12%，表现异常强劲。</p>
<p>其交易量刚刚激增至 1860 万股，而其日均交易量约为 567 万股。这一切都要归功于三个关键催化因素。</p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2024/05/shutterstock_2339707233-scaled.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2024/05/shutterstock_2339707233-scaled.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<h2><strong>本文的关键点</strong></h2>
<ul>
<li>Tempus AI（纳斯达克代码：TEM）上涨约 12%，得益于三个关键催化因素。</li>
<li>首先，Tempus AI 刚刚收购了 Ambry Genetics。</li>
<li>其次，南希·佩洛西和凯西·伍德对 Tempus AI 持乐观态度。</li>
<li>第三，TD Cowen 刚刚将 TEM 股票评级上调至买入，目标价为 74 美元。</li>
<li>如果你在寻找更多股票投资建议，别忘了获取我们的 <strong>“下一个 NVIDIA”</strong> 报告，该报告免费提供。报告详细介绍了 NVIDIA 与一只在 2024 年上涨 114% 的股票之间的竞争。该报告包含了关于顶级 AI 股票的研究，限时免费提供。</li>
</ul>
<h2><strong>催化因素一：Tempus AI 刚刚收购了 Ambry Genetics</strong></h2>
<p>Tempus AI 刚刚以 6 亿美元收购了知名的基因检测领导者 Ambry Genetics，其中包括 3.75 亿美元的现金支付和 2.25 亿美元的股票。</p>
<p>根据 Tempus 创始人兼首席执行官埃里克·莱夫科夫斯基的说法，这次收购 “补充了我们利用诊断和数据推动创新的战略，进一步增强了我们为临床医生、患者和生命科学公司提供尖端解决方案的能力。”</p>
<p>这也预计将增强 Tempus AI 的产品供应，加速其实现正自由现金流和盈利的进程。此外，这将使 Tempus AI 接触到更多的基因检测领域，如儿科和心脏病学，而这些领域之前并没有接触。</p>
<h2><strong>催化因素二：南希·佩洛西对 Tempus AI 持乐观态度</strong></h2>
<p>南希·佩洛西在 1 月中旬通过购买 50 份 2026 年 1 月到期的 TEM 20 美元看涨期权，获得了 TEM 股票的股份。甚至凯西·伍德上个月也在多个基金中购买了约 60 万股。</p>
<p>事实上，<strong>“方舟投资对 TEM 的兴趣始于 12 月 6 日，当时 ARK 基因组革命 ETF 首次购买了该医疗科技公司的股票。自那时以来，Tempus AI 在方舟的投资组合中迅速上升，成为</strong> 第十大 <strong>持股，ARK 创新 ETF 的旗舰产品。TEM 现在占 ARKK 总资产的 3.2%，市值超过 2.65 亿美元，正如 Seeking Alpha 所指出的。”</strong></p>
<h2><strong>催化因素三：TD Cowen 刚刚将 Tempus AI 评级上调至买入</strong></h2>
<p>TD Cowen 的分析师刚刚将这只 AI 股票的评级上调至买入，目标价为 74 美元。</p>
<p>根据该公司的说法，最新的收购为 Tempus 提供了一个价值 3 亿美元的盈利性生殖系检测实验室。此外，这将增强 Tempus AI 的产品供应，并帮助其扩展到新领域，同时提供更清晰的正自由现金流路径。有什么不好呢？</p>
<p>这篇文章的标题为《为什么 Tempus AI（TEM）今天飙升》，最早出现在 24/7 Wall St.。</p>

<p>Tempus AI (NASDAQ:TEM) 的股价上涨了 12%，主要受到三个关键因素的推动：以 6 亿美元收购 Ambry Genetics、南希·佩洛西和凯西·伍德的支持，以及 TD Cowen 将其评级上调至买入，目标价为 74 美元。此次收购预计将增强 Tempus 的产品供应，加速其盈利之路，而这些支持也增加了投资者的兴趣，使 TEM 成为 Ark Invest 投资组合中的重要持股</p>

<p>Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive.</p>
<div class="lb-trans"><p>Tempus AI（纳斯达克代码：TEM）上涨约 12%，表现异常强劲。</p>
</div><p>Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three key catalysts.</p>
<div class="lb-trans"><p>其交易量刚刚激增至 1860 万股，而其日均交易量约为 567 万股。这一切都要归功于三个关键催化因素。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2024/05/shutterstock_2339707233-scaled.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2024/05/shutterstock_2339707233-scaled.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<h2><strong>Key Points About This Article</strong></h2>
<div class="lb-trans"><h2><strong>本文的关键点</strong></h2>
</div><ul>
<li>Up about 12%, Tempus AI (NASDAQ: TEM) is rocketing thanks to three key catalysts.</li>
<li>One, Tempus AI just acquired Ambry Genetics.</li>
<li>Two, Nancy Pelosi and Cathie Wood are bullish on Tempus AI.</li>
<li>Three, TD Cowen just upgraded the TEM stock to a buy with a $74 price target.</li>
<li>If you’re looking for more stock ideas, don’t forget to grab a copy of our <strong>“The Next NVIDIA”</strong> report that’s free. It details the war between NVIDIA and one stock that rose 114% in 2024. The report is loaded with research on top AI stocks and is available complimentary for a limited time.</li>
</ul>
<div class="lb-trans"><ul>
<li>Tempus AI（纳斯达克代码：TEM）上涨约 12%，得益于三个关键催化因素。</li>
<li>首先，Tempus AI 刚刚收购了 Ambry Genetics。</li>
<li>其次，南希·佩洛西和凯西·伍德对 Tempus AI 持乐观态度。</li>
<li>第三，TD Cowen 刚刚将 TEM 股票评级上调至买入，目标价为 74 美元。</li>
<li>如果你在寻找更多股票投资建议，别忘了获取我们的 <strong>“下一个 NVIDIA”</strong> 报告，该报告免费提供。报告详细介绍了 NVIDIA 与一只在 2024 年上涨 114% 的股票之间的竞争。该报告包含了关于顶级 AI 股票的研究，限时免费提供。</li>
</ul>
</div><h2><strong>Catalyst No. 1: Tempus AI Just Acquired Ambry Genetics</strong></h2>
<div class="lb-trans"><h2><strong>催化因素一：Tempus AI 刚刚收购了 Ambry Genetics</strong></h2>
</div><p>Tempus AI just acquired Ambry Genetics, a well-known leader in genetic testing, for $600 million, which includes $375 million in cash payments and $225 million in shares.</p>
<div class="lb-trans"><p>Tempus AI 刚刚以 6 亿美元收购了知名的基因检测领导者 Ambry Genetics，其中包括 3.75 亿美元的现金支付和 2.25 亿美元的股票。</p>
</div><p>And, according to Eric Lefkofsky, Founder and CEO of Tempus, the acquisition “complements our strategy of leveraging diagnostics and data to drive innovation, further strengthening our ability to deliver cutting-edge solutions to clinicians, patients, and life sciences companies.”</p>
<div class="lb-trans"><p>根据 Tempus 创始人兼首席执行官埃里克·莱夫科夫斯基的说法，这次收购 “补充了我们利用诊断和数据推动创新的战略，进一步增强了我们为临床医生、患者和生命科学公司提供尖端解决方案的能力。”</p>
</div><p>It’s also expected to strengthen Tempus AI’s product offerings and accelerate its road to positive free cash flow and profitability. Plus, it’ll expose Tempus AI to even more genetic testing in specialties such as pediatrics and cardiology, which it didn’t have exposure to before.</p>
<div class="lb-trans"><p>这也预计将增强 Tempus AI 的产品供应，加速其实现正自由现金流和盈利的进程。此外，这将使 Tempus AI 接触到更多的基因检测领域，如儿科和心脏病学，而这些领域之前并没有接触。</p>
</div><h2><strong>Catalyst No. 2: Nancy Pelosi is Bullish on Tempus AI</strong></h2>
<div class="lb-trans"><h2><strong>催化因素二：南希·佩洛西对 Tempus AI 持乐观态度</strong></h2>
</div><p>Nancy Pelosi took a stake in the TEM stock by buying 50 of the TEM January 2026 $20 call options in mid-January. Even Cathie Wood picked up about 600,000 shares across multiple funds last month.</p>
<div class="lb-trans"><p>南希·佩洛西在 1 月中旬通过购买 50 份 2026 年 1 月到期的 TEM 20 美元看涨期权，获得了 TEM 股票的股份。甚至凯西·伍德上个月也在多个基金中购买了约 60 万股。</p>
</div><p>In fact, <strong>“Ark Invest’s interest in TEM began on December 6, when the ARK Genomic Revolution ETF made its initial purchase of shares in the healthcare technology company. Since then, Tempus AI has rapidly ascended within Ark’s portfolio, becoming the</strong> tenth-largest <strong>holding in the flagship Ark Innovation ETF. TEM now represents 3.2% of ARKK’s total assets, with a market value exceeding $265 million, as noted by Seeking Alpha.</strong></p>
<div class="lb-trans"><p>事实上，<strong>“方舟投资对 TEM 的兴趣始于 12 月 6 日，当时 ARK 基因组革命 ETF 首次购买了该医疗科技公司的股票。自那时以来，Tempus AI 在方舟的投资组合中迅速上升，成为</strong> 第十大 <strong>持股，ARK 创新 ETF 的旗舰产品。TEM 现在占 ARKK 总资产的 3.2%，市值超过 2.65 亿美元，正如 Seeking Alpha 所指出的。”</strong></p>
</div><h2><strong>Catalyst No. 3: TD Cowen Just Upgraded Tempus AI to a Buy</strong></h2>
<div class="lb-trans"><h2><strong>催化因素三：TD Cowen 刚刚将 Tempus AI 评级上调至买入</strong></h2>
</div><p>Analysts at TD Cowen just upgraded the AI stock to a buy rating, with a price target of $74.</p>
<div class="lb-trans"><p>TD Cowen 的分析师刚刚将这只 AI 股票的评级上调至买入，目标价为 74 美元。</p>
</div><p>According to the firm, the latest acquisition gives Tempus a $300 profitable germline testing lab. Plus, it’ll strengthen Tempus AI product offerings and help it expand into new territory. All while providing a clearer path to positive free cash flow. What’s not to like?</p>
<div class="lb-trans"><p>根据该公司的说法，最新的收购为 Tempus 提供了一个价值 3 亿美元的盈利性生殖系检测实验室。此外，这将增强 Tempus AI 的产品供应，并帮助其扩展到新领域，同时提供更清晰的正自由现金流路径。有什么不好呢？</p>
</div><p>The post Why Tempus AI (TEM) Is Soaring Today appeared first on 24/7 Wall St..</p>
<div class="lb-trans"><p>这篇文章的标题为《为什么 Tempus AI（TEM）今天飙升》，最早出现在 24/7 Wall St.。</p>
</div>

为什么 Tempus AI（TEM）今天股价飙升